Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)
CNY 80.33
(-2.26%)
CNY 80.33
(-2.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 91.09 Million CNY | 559.69% |
| 2022 | 13.8 Million CNY | -87.59% |
| 2021 | 111.27 Million CNY | 39.1% |
| 2020 | 80 Million CNY | -11.11% |
| 2019 | 90 Million CNY | 80.0% |
| 2018 | 50 Million CNY | 0.0% |
| 2017 | 50 Million CNY | -53.7% |
| 2016 | 108 Million CNY | -8.47% |
| 2015 | 118 Million CNY | -23.87% |
| 2014 | 155 Million CNY | 23.31% |
| 2013 | 125.7 Million CNY | 109.5% |
| 2012 | 60 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 239.59 Million CNY | -15.31% |
| 2024 Q1 | 109.8 Million CNY | 20.53% |
| 2024 Q2 | 280.87 Million CNY | 155.8% |
| 2023 Q3 | 61.8 Million CNY | -0.46% |
| 2023 Q4 | 91.09 Million CNY | 47.39% |
| 2023 FY | 91.09 Million CNY | 559.69% |
| 2023 Q1 | 13.18 Million CNY | -4.51% |
| 2023 Q2 | 62.09 Million CNY | 370.85% |
| 2022 Q3 | 18.65 Million CNY | 9.08% |
| 2022 Q2 | 17.1 Million CNY | 51.87% |
| 2022 Q1 | 11.26 Million CNY | -89.88% |
| 2022 Q4 | 13.8 Million CNY | -25.97% |
| 2022 FY | 13.8 Million CNY | -87.59% |
| 2021 Q2 | 133.93 Million CNY | 0.71% |
| 2021 Q4 | 111.27 Million CNY | 9.95% |
| 2021 Q1 | 132.99 Million CNY | 66.24% |
| 2021 FY | 111.27 Million CNY | 39.1% |
| 2021 Q3 | 101.21 Million CNY | -24.43% |
| 2020 Q4 | 80 Million CNY | -33.33% |
| 2020 FY | 80 Million CNY | -11.11% |
| 2020 Q2 | 120 Million CNY | 33.33% |
| 2020 Q1 | 90 Million CNY | 0.0% |
| 2020 Q3 | 120 Million CNY | 0.0% |
| 2019 Q2 | 100 Million CNY | 100.0% |
| 2019 FY | 90 Million CNY | 80.0% |
| 2019 Q1 | 50 Million CNY | 0.0% |
| 2019 Q4 | 90 Million CNY | 0.0% |
| 2019 Q3 | 90 Million CNY | -10.0% |
| 2018 Q1 | 50 Million CNY | 0.0% |
| 2018 Q4 | 50 Million CNY | 0.0% |
| 2018 FY | 50 Million CNY | 0.0% |
| 2018 Q3 | 50 Million CNY | 0.0% |
| 2018 Q2 | 50 Million CNY | 0.0% |
| 2017 Q2 | 50 Million CNY | 0.0% |
| 2017 Q3 | 50 Million CNY | 0.0% |
| 2017 Q4 | 50 Million CNY | 0.0% |
| 2017 FY | 50 Million CNY | -53.7% |
| 2017 Q1 | 50 Million CNY | -53.7% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 108 Million CNY | -8.47% |
| 2016 Q4 | 108 Million CNY | 0.0% |
| 2016 Q3 | 108 Million CNY | 0.0% |
| 2016 Q2 | 108 Million CNY | 0.0% |
| 2015 FY | 118 Million CNY | -23.87% |
| 2014 Q4 | 155 Million CNY | 2.85% |
| 2014 FY | 155 Million CNY | 23.31% |
| 2014 Q3 | 150.7 Million CNY | 0.0% |
| 2013 FY | 125.7 Million CNY | 109.5% |
| 2012 FY | 60 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |